Trial NCT04248465

View at ClinicalTrials.gov 
Org. Study IDs: ALXN1210-ALS-308
Secondary IDs: 2019-004619-30

Last trial update was posted on 2023-01-10

MeSH Interventions

Ravulizumab

MeSH Conditions

Amyotrophic Lateral Sclerosis Motor Neuron Disease Sclerosis

Other Conditions

ALS

Stopping Reasons

The IDMC recommended the study be discontinued due to lack of efficacy with ravulizumab.

Limitations And Caveats

The IDMC recommended the study be discontinued due to lack of efficacy with ravulizumab.

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID